What is the Risperdal Class Action Lawsuit About?

Risperdal (risperidone) is an antipsychotic medication prescribed to treat schizophrenia, bipolar disorder, and other mental health conditions. But emerging research has linked Risperdal and similar antipsychotic drugs to an increased risk of breast cancer, particularly among long-term users.

Now, lawsuits are being filed against Janssen Pharmaceuticals (a Johnson & Johnson company), alleging that the drug’s manufacturers failed to warn patients and healthcare providers about this life-altering risk.

If you were diagnosed with breast cancer after taking Risperdal, Invega, or Zyprexa, you may be eligible to file a claim. See if you qualify for a FREE case review – Click HERE!

How Does Risperdal Increase Breast Cancer Risk?

Risperdal is part of a class of drugs called atypical antipsychotics, which are known to increase prolactin levels. Prolactin is a hormone that plays a key role in breast tissue growth and lactation.

When prolactin stays elevated for extended periods, it may result in:

• Abnormal breast growth (gynecomastia in men, tissue changes in women)
• Hormonal imbalance
• Higher risk of developing breast cancer

A 2022 study analyzing the health records of more than 540,000 women found that:

• Women who used antipsychotic medications faced a 35% increased risk of developing breast cancer.
• Category 1 prolactin-elevating drugs, including Risperdal, were associated with a 62% higher risk of breast cancer.

Despite these results, numerous patients say they were never informed about this potential risk prior to beginning treatment.

Why Are Breast Cancer Patients Filing Lawsuits?

Lawsuits filed against Janssen Pharmaceuticals and other drug manufacturers center on failure to warn and corporate negligence. The claims assert that:

• Risperdal’s makers knew—or should have known—about the connection between prolactin elevation and breast cancer
• The company did not provide sufficient warnings to patients or prescribing physicians
• Marketing materials minimized the risks, preventing patients from making fully informed decisions about their treatment
• Some healthcare providers may have prescribed Risperdal without knowledge of safer alternatives for certain patients

If you were diagnosed with breast cancer after using Risperdal or a similar antipsychotic, you might be eligible to pursue legal action.Click HERE for a FREE case review with an attorney experienced in pharmaceutical lawsuits.

Who Qualifies for a Risperdal Breast Cancer Lawsuit?

You may be eligible to file a Risperdal breast cancer claim if:

• You are a woman diagnosed with breast cancer
• You took Risperdal, Invega, or Zyprexa (including generic versions)
• You used the medication for at least 2 years
• You began taking the medication after 2014

Even if your doctor never warned you about the risk of breast cancer, you may still have a valid claim. These lawsuits focus on what the manufacturer knew and failed to disclose to patients and healthcare providers.

What Types of Compensation Might Be Available?

Breast cancer can impact nearly every aspect of life, from health and finances to emotional wellbeing. Plaintiffs in Risperdal breast cancer lawsuits may seek compensation for:

• Medical expenses: Including surgeries, chemotherapy, radiation, and follow-up care
• Lost income and reduced earning potential: Time off work or inability to return to previous employment
• Physical pain and suffering: From treatments, side effects, and long-term complications
• Emotional distress: The mental and psychological impact of a cancer diagnosis and treatment
• Diminished quality of life: Affecting daily activities and future plans
• Punitive damages: To hold drug manufacturers accountable for failing to disclose safety risks

Why Is This Issue Drawing Increased Attention Now?

For many years, studies indicated that antipsychotic medications such as Risperdal can raise prolactin levels, and more recent research has established a direct connection to higher breast cancer risk. This has resulted in:

• New lawsuits being filed nationwide
• Greater scrutiny of pharmaceutical marketing practices
• Heightened awareness among current and former patients who were not warned about these risks

The convergence of medical research and ongoing lawsuits has pushed this issue into the national spotlight.

Steps to Take If You’ve Been Affected

If you were diagnosed with breast cancer after taking Risperdal or similar medications, consider taking these steps:

• Gather medical records: Collect documentation of your cancer diagnosis, treatment history, and prescription details.
• Consult your healthcare provider: Review your medication history and check if prolactin levels or related concerns were monitored.
• Seek legal advice: An experienced attorney can evaluate your case and outline your legal options.
• Act promptly: Statutes of limitations differ by state, so it’s important to move quickly.

How Injury Claims Can Help

At Injury Claims, we collaborate with attorneys who are actively handling Risperdal breast cancer lawsuits. Our legal partners recognize the emotional and financial impact of a cancer diagnosis and are dedicated to helping patients pursue justice.

If you were diagnosed with breast cancer after taking Risperdal, Invega, or Zyprexa, click HERE to start your FREE case review today.